[1] 王 烁, 郑 平, 鲁 兵, 等. 炎性小体激活与细胞焦亡在急性胰腺炎中的研究进展[J]. 胃肠病学和肝病学杂志, 2024, 33(10):1416-1421.
[2] 中华医学会急诊分会, 京津冀急诊急救联盟, 北京医学会急诊分会, 等. 急性胰腺炎急诊诊断及治疗专家共识[J]. 中华急诊医学杂志, 2021, 30(2):161-172.
[3] Gliem N, Ammer-Herrmenau C, Ellenrieder V, et al. Management of severe acute pancreatitis: an update[J]. Digestion, 2021, 102(4): 503-507.
[4] 龚 亮. 急性胰腺炎患者肠道菌群的多样性及其与病情严重度的相关性研究[D]. 北京:协和医学院, 2023.
[5] 赵成思, 陈安宁, 白 慧, 等. 急性胰腺炎早期胰液细菌培养的特征及临床意义[J]. 中国普通外科杂志, 2023, 32(3): 424-433.
[6] Glaubitz J, Wilden A, Frost F, et al. Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis[J]. Gut, 2023, 72(7): 1355-1369.
[7] 王春敏, 韩桂华, 马淑霞. 短链脂肪酸对肠黏膜屏障的影响[J]. 中国微生态学杂志, 2022, 34 (12): 1471-1475.
[8] Ding L, Chen H Y, Wang J Y, et al. Severity of acute gastrointestinal injury grade is a good predictor of mortality in critically ill patients with acute pancreatitis[J]. World J Gastroenterol, 2020, 26(5):514-523.
[9] Sivaprakasam S, Prasad P D, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis[J] Pharmacol Ther, 2016, 164:144-151.
[10] Gao Y, Davis B, Zhu W, et al. Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo[J]. Am J Physiol Gastrointest Liver Physiol, 2021, 320(4):G521-G530.
[11] Xiao S, Jing S, Jiakui S, et al. Butyrate ameliorates intestinal epithelial barrier injury via enhancing foxp3+ regulatory t-cell function in severe acute pancreatitis model[J]. Turk J Gastroenterol, 2022, 33(4):710-719.
[12] Zhao H B, Jia L, Yan Q Q, et al. Effect of clostridium butyricum and butyrate on intestinal barrier functions: study of a rat model of severe acute pancreatitis with intra-abdominal hypertension[J]. Front Physiol, 2020, 11:561061-561061.
[13] Sun J, Furio L, Mecheri R, et al. Pancreatic β-Cells Limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota[J]. Immunity, 2015, 43(2):304-317.
[14] Pan X, Fang X, Wang F, et al. Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanism[J]. Br J Pharmacol, 2019, 176(23):4446-4461.
[15] Lei Y, Tang L, Liu S, et al. Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration[J]. Microbiome, 2021, 9(1):115.
[16] Xiong Y, Ji L, Zhao Y, et al. Sodium Butyrate attenuates taurocholate-induced acute pancreatitis by maintaining colonic barrier and regulating gut microorganisms in mice[J]. Front Physiol, 2022, 13:813735.
[17] Zhang T, Xia M, Zhan Q, et al. Sodium butyrate reduces organ injuries in mice with severe acute pancreatitis through inhibiting HMGB1 expression[J]. Dig DisSci, 2015, 60(7):1991-1999.
[18] Wang F, Liu J, Weng T, et al. The inflammation induced by lipopolysaccharide can be mitigated by short-chain fatty acid, butyrate, through upregulation of IL-10 in septic shock[J]. Scand J Immunol, 2017, 85(5):258-263.
[19] Xu M, Wang C, Li N, et al. Intraperitoneal injection of acetate protects mice against lipopolysaccharide (LPS)-Induced acute lung injury through its anti-inflammatory and anti-oxidative ability[J]. Med Sci Monit, 2019, 25:2278-2288.
[20] Karoor V, Strassheim D, Sullivan T, et al. The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension[J]. Int J Mol Sci, 2021, 22(18):9916.
[21] Devani K, Charilaou P, Radadiya D, et al. Acute pancreatitis: Trends in outcomes and the role of acute kidney injury in mortality-A propensity-matched analysis[J]. Pancreatology, 2018, 18(8):870-877.
[22] Andrade-Oliveira V, Amano M T, Correa-Costa M, et al. Gut bacteria products prevent AKI Induced by ischemia-reperfusion[J]. J Am Soc Nephrol, 2015, 26(8):1877-1888.
[23] O’Keefe S J, Ou J, Delany J P, et al. Effect of fiber supplementation on the microbiota in critically ill patients[J]. World J GastrointestPathophysiol, 2011, 2(6):138-145.
[24] Karakan T, Ergun M, Dogan I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study[J]. World J Gastroenterol, 2007, 13(19):2733-2737.
[25] Besselink M G, van Santvoort H C, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2008, 371 (9613):651-659.
[26] 崔立红, 王晓辉, 彭丽华, 等. 早期场内营养加微生态制剂对重症胰腺炎患者疗效的影响[J]. 中华危重病急救医学, 2013, 25(4):224-228.
[27] Sharma B, Srivastava S, Singh N, et al. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial[J]. Clin Gastroenterol, 2011, 45:442-448.
[28] Yu C, Zhang Y, Yang Q, et al. An updated systematic review with meta-analysis: efficacy of prebiotic, probiotic, and synbiotic treatment of patients with severe acute pancreatitis[J]. Pancreas, 2021, 50:160-166.
[29] Wang J, Jiang M, Hu Y, et al. Lactulose regulates gut microbiota dysbiosis and promotes short-chain fatty acids production in acute pancreatitis patients with intestinal dysfunctioniotic, probiotic, and synbiotic treatment of patients with severe acute pancreatitis?[J]. Biomed Pharmacother, 2023, 163:114769.
[30] Rohith G, Sureshkumar S, Anandhi A, et al. Effect of synbiotics in reducing the systemic inflammatory response and septic complications in moderately severe and severe acute pancreatitis: a prospective parallel-arm double-blind randomized trial[J]. Dig Dis Sci, 2023, 68:969-977.
[31] Gibson G R, Hutkins R, Sanders M E, et al. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(8):491-502.
[32] van den Berg F F, van Dalen D, Hyoju SK, et al. Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrat[J]. Gut, 2021, 70(5):915-927.
[33] Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice[J]. Gut, 2017, 66(5):569-580.
[34] DeFilipp Z, Bloom P P, Torres Soto M, et al. Drug-resistant e. coli bacteremia transmitted by fecal microbiota transplant[J]. N Engl J Med, 2019, 381(21):2043-2050.
[35] Nicholson M R, Hourigan S K, Conrad M, et al. Current challenges in fecal microbiota transplantation for clostridioides difficile infection in children[J]. Am J Gastroenterol, 2021, 116 (21): 1954-1956.